Targeting Neuroinflammation via Purinergic P2 Receptors for Disease Modification in Drug-Refractory Epilepsy
Tobias Engel,1,2,* Jonathon Smith,1,2,* Mariana Alves1 1Department of Physiology and Medical Physics, Royal College of Surgeons in Ireland, University of Medicine and Health Sciences, Dublin, D02 YN77, Ireland; 2FutureNeuro, Science Foundation Ireland Research Centre for Chronic and...
Saved in:
Main Authors: | Engel T (Author), Smith J (Author), Alves M (Author) |
---|---|
Format: | Book |
Published: |
Dove Medical Press,
2021-07-01T00:00:00Z.
|
Subjects: | |
Online Access: | Connect to this object online. |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
The Metabotropic Purinergic P2Y Receptor Family as Novel Drug Target in Epilepsy
by: Mariana Alves, et al.
Published: (2018) -
Purinergic Signaling in Neuroinflammation
Published: (2023) -
Editorial: Purinergic signaling and neuroinflammation
by: Charles Elias Assmann, et al.
Published: (2022) -
Purinergic P2 Receptors: Novel Mediators of Mechanotransduction
by: Qihang Kong, et al.
Published: (2021) -
Interaction of Purinergic P2X4 and P2X7 Receptor Subunits
by: Markus Schneider, et al.
Published: (2017)